Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Contrast Enhanced ICE for Myocardial Scar Localization in VT Ablation
NCT03212326Completed
- Sponsor
- Weill Cornell Medicine
- Start
- Mar 2013
- Primary completion
- Sep 2018
- Modality
- Drug Delivery Systems
01
Overview
Open-label, single-arm trial of perflutren in ventricular tachycardia (VT), sponsored by Weill Cornell Medicine. Primary endpoint: Number of Subjects With Myocardial Scar on Echo and Voltage Maps at Day 0. Started Mar 2013; status: completed.
02
Drugs
perflutren
03
Conditions
ventricular tachycardia (VT)
Beyond the preview
Go deeper on NCT03212326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03212326.